Skip to main content
. 2017 Jul 17;8(46):80521–80530. doi: 10.18632/oncotarget.19298

Table 3. The diagnostic performance of four markers and ANN models for all stages HCC and early stage HCC cases in cirrhotic patients.

Markers HCC vs LC Early HCC vs LC
AUC p Value Cut-off Sensitivity Specificity AUC p Value Cut-off Sensitivity Specificity
AFP(ng/mL) 0.713(0.659-0.767) <0.001  49.4 0.564 0.822 0.650(0.575-0.725) <0.001  43.7 0.469 0.809
GP73(ng/mL) 0.618(0.559-0.677) <0.001 148.6 0.921 0.344 0.703(0.630-0.776) <0.001 181.4 0.770 0.593
AFP-L3(ng/mL) 0.730(0.678-0.782) <0.001 8.028 0.523 0.895 0.672(0.597-0.748) <0.001       3.813 0.494 0.842
DCP(mAU/mL) 0.764(0.714-0.814) <0.001  28.1 0.621 0.855 0.609(0.527-0.690) 0.006  13.7 0.605 0.645
MLP-Models 0.753(0.701-0.806) <0.001   0.5 0.697 0.809 0.692(0.616-0.768) <0.001   0.5 0.469 0.914
RBF-Models 0.742(0.688-0.795) <0.001   0.5 0.733 0.750 0.659(0.582-0.735) <0.001   0.5 0.481 0.836